Literature DB >> 925739

Cerebral arterial blood flow and aneurysm surgery. Part 2: Induced hypotension and autoregulatory capacity.

H Nornes, H B Knutzen, P Wikeby.   

Abstract

A study of 21 patients was conducted to clarify the autoregulatory capacity in patients subjected to induced hypotension during intracranial surgery for saccular aneurysms. Trimethaphan camsylate (Arfonad) was used for induced hypotension and arterial blood flow was measured with an electromagnetic flow probe on the internal carotid artery or one of its main intracranial branches. In Grade I and II patients the control arterial blood pressure (ABP) ranged from a mean of 90 to 135 mm Hg (average 110 mm Hg), with a lower level of autoregulation (LLAR) from 35 to 85 mm Hg (average 62 mm Hg). Grade III patients had a control ABP of between 105 and 145 mm Hg (average 124 mm Hg) and the LLAR was found to be between 60 and 95 mm Hg (average 76 mm Hg). There was a significant difference between the two groups with regard to both the control ABP and the LLAR. A surprising result obtained from these data was that the average lower autoregulatory range (the difference between control ABP and LLAR) is practically the same in the two groups. A systematic investigation of the upper limit of autoregulation was not possible for ethical reasons. In those few patients in whom spontaneous increase in the ABP made such observations possible, upper limits up to 150 mm Hg with a total autoregulatory capacity of about 75 mm Hg were observed. In some patients, however, lower limits and cing that the upper limit of autoregulation is markedly influenced by several factors.

Entities:  

Mesh:

Year:  1977        PMID: 925739     DOI: 10.3171/jns.1977.47.6.0819

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  20 in total

1.  Late effects of subarachnoid haemorrhage on the response of the primate cerebral circulation to drug-induced changes in arterial blood pressure.

Authors:  J D Pickard; D P Boisvert; D I Graham; W Fitch
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-10       Impact factor: 10.154

2.  A bedside test for cerebral autoregulation using transcranial Doppler ultrasound.

Authors:  C A Giller
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

3.  Self-retaining brain retractor pressure during intracranial procedures.

Authors:  J Rosenørn
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

Review 4.  Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.

Authors:  Darcy Lidington; Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

Review 5.  Cerebral vasospasm: a consideration of the various cellular mechanisms involved in the pathophysiology.

Authors:  Jacob Hansen-Schwartz
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Longitudinal study of cerebral blood flow following early or delayed surgery for ruptured intracranial aneurysms.

Authors:  G L Viale; E V Sehrbundt; M Cossu; C Viola; G Rodriguez; A Pau; C Bernucci
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Intraoperative Doppler and real time sonography in neurosurgery.

Authors:  J M Gilsbach; W E Hassler
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

8.  Cortical blood flow recorded during early or delayed surgery for ruptured intracranial aneurysms.

Authors:  G L Viale; M Cossu; F Cella; M Balestrero; A Rossi; D Masoni
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Early complications and results of surgery for ruptured intracranial aneurysms.

Authors:  R V Jeffreys
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

10.  Neonatal cerebral blood flow velocity responses to changes in posture.

Authors:  M Y Anthony; D H Evans; M I Levene
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.